Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial-Reference-Cited by-同舟云学术

Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial

Published:2014-05-19 Issue:5 Volume:9 Page:e97803
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Meininger Vincent,Pradat Pierre-François,Corse Andrea,Al-Sarraj Safa,Rix Brooks Benjamin,Caress James B.,Cudkowicz Merit,Kolb Stephen J.,Lange Dale,Leigh P. Nigel,Meyer Thomas,Milleri Stefano,Morrison Karen E.,Orrell Richard W.,Peters Gary,Rothstein Jeffrey D.,Shefner Jeremy,Lavrov Arseniy,Williams Nicola,Overend Phil,Price Jeffrey,Bates Stewart,Bullman Jonathan,Krull David,Berges Alienor,Abila Bams,Meno-Tetang Guy,Wurthner Jens

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS;DW Cleveland;Neuron,1999

2. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology;RG Miller;Neurology,2009

3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND);RG Miller;Cochrane Database Syst Rev (Online),2012

4. Motor neuron disease: the bare essentials;K Talbot;Pract Neurol,2009

5. Prevalence and patterns of cognitive impairment in sporadic ALS;GM Ringholz;Neurology,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling;Antibodies;2024-07-09

2. Biomarkers in amyotrophic lateral sclerosis: current status and future prospects;Nature Reviews Neurology;2023-11-10

3. Therapeutic targeting ofALSpathways: Refocusing an incomplete picture;Annals of Clinical and Translational Neurology;2023-08-28

4. Central nervous system demyelinating diseases: glial cells at the hub of pathology;Frontiers in Immunology;2023-05-16

5. Unveiling the modulation of Nogo receptor in neuroregeneration and plasticity: Novel aspects and future horizon in a new frontier;Biochemical Pharmacology;2023-04